| # | Drug | Count |
|---|---|---|
| 0 | AVALGLUCOSIDASE ALFA-NGPT | 2 |
| 1 | ADALIMUMAB | 1 |
| 2 | AGALSIDASE BETA | 1 |
| 3 | AZATHIOPRINE | 1 |
| 4 | BELIMUMAB | 1 |
| 5 | CALCIUM | 1 |
| 6 | ERGOCALCIFEROL | 1 |
| 7 | HYDROXYCHLOROQUINE | 1 |
| 8 | LEVOCARNITINE | 1 |
| 9 | LEVOCARNITINE ORAL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVALGLUCOSIDASE ALFA-NGPT | 2 | 0.0020 |
| 1 | LEVOCARNITINE | 1 | 0.0003 |
| 2 | AGALSIDASE BETA | 1 | 0.0001 |
| 3 | ERGOCALCIFEROL | 1 | 0.0000 |
| 4 | BELIMUMAB | 1 | 0.0000 |
| 5 | AZATHIOPRINE | 1 | 0.0000 |
| 6 | TACROLIMUS OINTMENT 0.1% | 1 | 0.0000 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 1 | 0.0000 |
| 8 | MYCOPHENOLATE MOFETIL | 1 | 0.0000 |
| 9 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 1 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 6 | Calcium [EPC] | 1 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 2 | 0.0000 |